Gene and cell therapy

Gene-editing strategies that allow stem cells to evade the immune system offer hope for universal cell-replacement therapies.

Directed evolution uses diversity and competitive selection to make genetic-medicine vectors that deliver their cargo to target tissues more efficiently at lower doses.

Laboratory assessments — from preclinical research through post-marketing surveillance — determine whether a cell-based therapy for cancer succeeds or fails.